GIST tumours and soft tissue sarcomas

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME

The parotid gland; an unusual site of colorectal cancer metastasis

ASCO 2023: Highlights and analysis

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment for pStage III G/GEJ cancer

Maximising diagnosis of colon cancer with target screening